NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Findings from R. Sharma and co-authors broaden understanding of breast cancer



June 18th, 2009

According to recent research from Delhi, India, " The diagnostic utility of a C-11-methionine scan has been established in breast cancer. We were able to radiolabel methionine with Tc-99m at our institute."

"Thus, we undertook clinical trials to determine the role of Tc-99m-methionine scans in the detection of breast cancer. Scintimammography was performed in 47 female (median age 44 years, range 28-68 years) patients having palpable breast masses. All of them underwent ultrasound, mammography, fine-needle aspiration cytology, and Tc-99m-methionine scintimammography before surgery. The final diagnosis was made after histopathological examination. Tc-99m-methionine...


Source: Women's Health Weekly (2009-06-18)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login